We're taking Presidents Day off

FierceBiotech and its sister publications won't be publishing Monday as we observe Presidents Day. Our three daily publications and the usual Monday weeklies, FierceCRO (subscribe) and FierceBiotechIT (subscribe), will be sent to you on Tuesday, Feb. 19. You will also receive FierceBiotechResearch (subscribe) and FiercePharmaManufacturing (subscribe) Tuesday as usual.

FierceBiotech, FiercePharma, and FierceMedicalDevices each published a new special report this week:

  • The 25 most influential people in biopharma today - 2013
  • Top Biopharma M&A Deals - 2012
  • R&D advances in cancer Dx

 

Enjoy the long weekend! -- Jennifer Levin (email | Twitter)

Suggested Articles

Astellas will develop Frequency's hearing loss drug outside the U.S. in exchange for $80 million upfront and the promise of $545 million down the line.

Inovio Pharmaceuticals is cutting 28% of its workforce and swinging the ax to a bladder cancer test.

The agency was less likely to go against a recommendation when the panellists were united in their opinion.